The acquisition proposal from Tang Capital Partners and Concentra to acquire all outstanding common stock of Atea Pharmaceuticals directly impacts the company. If the acquisition goes through, it could lead to a change in the company's management, strategy, and potentially its stock price. The news is highly relevant and important for investors in Atea Pharmaceuticals, as it could affect the value of their holdings.